HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan Pursues Biotech-Based Fragrance, Unveils ‘Wellbeing Solutions’ For Boomers

Executive Summary

Givaudan will be working with LanzaTech NZ to develop fragrance ingredients the biotech way, and is launching a Silver Radiance program to meet the wellness needs of adults over the age of 55. Meanwhile, the firm’s fine fragrance sales in the first nine months of 2022 jumped 14.8%.

You may also be interested in...



Shiseido Heralds Partnership To Build Circular Economy For Cosmetics Packaging

Tokyo-based Shiseido Company Ltd. has joined with two Japanese plastics manufacturers to create a circular economy for cosmetics packaging that they will invite other cosmetic firms to join.

Arcaea CEO On Biotech’s Promise: Sustainable, Yes, But Ingredient Performance Will Drive Adoption

With biotech, “the entire tree of life starts to become accessible to us ethically and sustainably,” says Arcaea CEO Jasmina Aganovic. Her company, launched in October 2021, is developing custom keratin molecules for skin and hair, as well as new UV filter technology, among other innovations to expand formulators’ toolkits, not just replace problematic ingredients.

Coty To Improve Fragrance Sustainability; Ulta Bringing Beauty Into Loop; Cosmetics News In Brief

Coty and Ulta Beauty announce sustainability initiatives, Whole Foods declares 2021 clean beauty trends, and e.l.f. Cosmetics prepares to launch a Chipotle burrito-inspired makeup collection.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel